Loading...
Although some clinicians manage bothersome low sexual desire by administering testosterone (T), no formulation specifically for women is available in most countries, including the U.S. Thus, researchers conducted a systematic review and meta-analysis of randomized, controlled trials of T in women. The study focused transdermal patches releasing 300 µg T daily (resulting in blood T levels at the upper end of the premenopausal range) or nontransdermal formulations at doses achieving blood T levels close to those attained with the patch. Of the 36 trials (8480 participants), most were 12 to 24 weeks in length and the longest duration was 2 years.
Compared with placebo (or a comparator such as menopausal estrogen with or without progestin), T si…